Access cutting-edge b-all treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access b-all specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related b-all treatment provided free
This study will evaluate the use of non- TBI (total body irradiation) conditioning for B-ALL patients with low risk of relapse as defined by absence of NGS-MRD (next generation sequencing minimal residual disease) before receiving a hematopoietic cell transplant (HCT). Patients diagnosed with B-ALL who are candidates for HCT will be screened by NGS-MRD on a test of bone marrow done before the HCT. Subjects who are pre-HCT NGS-MRD negative will be eligible to receive a non-TBI conditioning regime
Sponsor: Pediatric Transplantation & Cellular Therapy Consortium
Check if you qualify for this b-all clinical trial in Birmingham, AL
If you're searching for b-all treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced b-all specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.